Syndax Pharmaceuticals Inc (SNDX)
SBC to Revenue
19.25%
Quarterly · Period ending:
SNDX SBC to Revenue
Latest reported19.25%period ending
Latest reported19.25%period ending
SNDX Quarterly SBC/Revenue (0.00% → 19.25%)
Latest values, visible window
High-resolution chart · PNG
SNDX sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 19.2518% | |
| 18.5835% | |
| 16.4338% | |
| 26.3391% | |
| 36.3217% | |
| 51.7912% | |
| 160.1172% | |
| 95.472% | |
| 282.7429% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 3.1041% | |
| 27.3212% | |
| 854.8813% | |
| 730.0792% | |
| 535.5263% | |
| 808.1794% | |
| 562.0053% | |
| 482.5858% | |
| 401.3158% | |
| 408.971% | |
| 353.0343% | |
| 420.0528% | |
| 387.3684% | |
| 458.3113% | |
| 414.5119% | |
| 374.934% | |
| 107.2925% | |
| 440.9836% | |
| 474.7541% | |
| 451.4754% | |
| 310.4918% | |
| 259.6721% | |
| 255.4098% | |
| 718.0328% | |
| 383.6066% | |
| 422.2951% | |
| 6,470.5882% | |
| 0% | |
| 0% | |
| 73.6667% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |